ArticleJournal of chemical information and modeling2026
Fine-Tuning DiffDock-L for Allosteric Kinase Docking.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CAFE: A Co-folding Approach for Fragment Exploration of Allosteric and Cryptic Binding Sites.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Allosteric kinase inhibitors are an important modality for overcoming resistance and achieving selectivity, yet most structure-based docking and deep generative models are trained predominantly on orthosteric protein-ligand complexes. As a result, current methods often misplace allosteric kinase ligands into the adenosine triphosphate (ATP)-binding site and fail to recover the correct binding mode. Here we curate AlloSet, a kinome-wide, time-split data set of kinase-ligand complexes annotated by binding mode, to systematically evaluate and fine-tune the diffusion-based docking model DiffDock-L for allosteric pose prediction. We explore several fine-tuning strategies, including increased dropout, freezing of torsion parameters with translation/rotation-only fine-tuning, and molecular dynamics-based supersampling of receptor conformations and ligand poses. The resulting DiffDock-L-Allo model is found to markedly improve pose-recovery metrics for Type III/IV allosteric binders while preserving the performance on ATP-site ligands. Binding-mode-resolved evaluations and comparisons with cofolding models such as AlphaFold3 and Boltz-2 highlight how targeted retraining reshapes the generative model's sampling distribution, offering practical guidance for adapting AI-driven docking to challenging, low-data binding modes in kinase structure-based drug design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.